510(k) K140455
K140455 is an FDA 510(k) premarket notification submitted by Trinity Biotech USA for the device "CAPTIA MEASLES IGM". The FDA issued a decision of Substantially Equivalent on May 22, 2014. The device falls under product code PCL (Enzyme Linked Immunoabsorbent Assay, Rubeola Igm), a Class I device regulated under 21 CFR 866.3520. Trinity Biotech USA has 10 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- May 22, 2014
- Date Received
- Feb 24, 2014
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Enzyme Linked Immunoabsorbent Assay, Rubeola Igm
- Device Class
- Class I
- Regulation Number
- 866.3520
- Review Panel
- MI
- Submission Type
- 510(k) Exempt
The qualitative detection of measles specific IgM antibodies in serum or plasma.
Need the full FDA record for Trinity Biotech USA? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.